This Company Has Better Numbers than Tilray at 1/25th the Price

Here during NFTRH’s 10th anniversary week it is interesting that one of our earliest subscribers, Frederick Lacy, has a well written and well researched article on the one Cannabis related stock I own, CV Sciences (CVSI).

Fred is one of my 3 (fundamental) Amigos watching over the junior precious metals miner patch, but he is also well versed in many other areas. Early on he pitched me on a complimentary NFTRH subscription for his views on individual stocks. It’s been a good trade for me over these last 10 years.

Fred does not often write publicly so I have never identified him beyond “Fred” or “Fred L”. But in the widely published article below his full name and company are credited.

As a side note, Fred is the one who called NFTRH the “best of breed” several years ago and coming from him, it meant a lot. In other words, the quote is real, not made up by me as a marketing jingle. And it comes from a knowledgeable source, obviously.

Anyway, check out this article on CVSI. Well done research.

This Company Has Better Numbers than Tilray at 1/25th the Price

It’s been a hard stock to hold (although I’ve traded ‘trading’ shares a couple times very successfully), but Fred’s research has helped me stay strong, especially during the Citron fiasco [edit] which actually worked to my favor in buying back, but the aftershocks were something to behold.

Subscribe to NFTRH Premium (monthly at USD $33.50 or a 14% discounted yearly at USD $345.00) for an in-depth weekly market report, interim market updates and NFTRH+ chart and trade setup ideas, all archived/posted at the site and delivered to your inbox.

You can also keep up to date with plenty of actionable public content at by using the email form on the right sidebar and get even more by joining our free eLetter. Or follow via Twitter @BiiwiiNFTRH, StockTwits or RSS. Also check out the quality market writers at